Business News

Travere Therapeutics stock hits 52-week high at 61.76 USD

FinSiddhi

Travere Therapeutics stock hits 52-week high at 61.76 USD
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.

Related Posts

Ahead of Market: 10 things that will decide D-Street action on Monday

Indian markets closed marginally higher on Thursday after a volatile expiry session, with the Sensex rising 109 points to 77,100.47 and the Nifty gaining 34 points to 24,056 after giving up intraday gains. Sentiment stayed mixed amid profit booking, FII outflows and macro cues, while global equities ended weak. Markets were shut on Friday for…

Gold prices fall Rs 1,300/10 gram; silver tanks Rs 5,600/kg as rate hike bets, US-Iran tensions dent mood. Time to sell precious metals?

Gold and silver prices tumbled on Wednesday as fading hopes for a U.S.-Iran peace deal fueled inflation worries and bolstered expectations of sustained high interest rates from the Federal Reserve. MCX silver futures saw a significant drop, while gold futures also declined. Analysts advise caution, suggesting investors await the Federal Reserve Chair’s speech before making…